logo

For the Inventor, By the Inventor

Deep River, CT, United States of America

Erin M Duffy

USPTO Granted Patents = 22 

 

Average Co-Inventor Count = 4.0

ph-index = 7

Forward Citations = 104(Granted Patents)


Location History:

  • New Haven, CT (US) (2018)
  • Deep River, CT (US) (2004 - 2024)

Company Filing History:

goldMedal9 out of 22 
 
Bioversys Ag
 patents
silverMedal8 out of 23 
 
Melinta Therapeutics, Inc.
 patents
bronzeMedal2 out of 17 
 
Rib-x Pharmaceuticals, Inc.
 patents
4. 1 out of 4,455 
 
Pfizer Corporation
 patents
5. 1 out of 13 
 
Melinta Subsidiary Corp.
 patents
6. 1 out of 1 
 
Melinta Subsidary Corp.
 patent

Years Active: 2004-2025

Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents
1. 12297201 - Substituted pyrrolo[2,3-d]pyrimidines as antimicrobials (2025-05-13),
2. 12234238 - Antimicrobial compounds and methods of making and using the same (2025-02-25),
3. 12152031 - Biodefense agents (2024-11-26),
4. 12036219 - Methods of treating infections in overweight and obese patients using antibiotics (2024-07-16),
5. 11999739 - Antimicrobials methods of making and using the same (2024-06-04),
6. 11098047 - Antimicrobials and methods of making and using same (2021-08-24),
7. 10947237 - Antimicrobial compounds and methods of making and using the same (2021-03-16),
8. 10934295 - Antimicrobials and methods of making and using same (2021-03-02),
9. 10815238 - Antimicrobial compounds and methods of making and using the same (2020-10-27),
10. 10815237 - Antimicrobials and methods of making and using same (2020-10-27),
11. 10471046 - Method for treating, preventing, or reducing the risk of skin infection (2019-11-12),
12. 10259825 - Antimicrobial compounds and methods of making and using the same (2019-04-16),
13. 10106543 - Antimicrobial compounds and methods of making and using the same (2018-10-23),
14. 9845297 - Antimicrobial compounds and methods of making and using the same (2017-12-19),
15. 9573962 - Antimicrobial compounds and methods of making and using the same (2017-02-21),

Title: A Spotlight on Erin M. Duffy: Innovator in Antimicrobial Solutions

Introduction

Erin M. Duffy, based in Deep River, Connecticut, is an accomplished inventor with a remarkable portfolio of 21 patents. His work primarily focuses on developing novel antimicrobial compounds and methods that address some of the most pressing health challenges related to microbial infections.

Latest Patents

Duffy’s latest patents revolve around two significant areas. The first involves antimicrobial compounds, wherein he discloses methods for creating and utilizing these compounds to treat, prevent, and reduce the risk of microbial infections in both humans and animals. Specifically, he presents a compound of Formula (I) designed to enhance the effectiveness of treatments against various microbial threats.

The second patent centers on biodefense agents, providing methods for addressing infections caused by microorganisms that could be used as biological weapons. This innovative approach involves administering a pyrrolocytosine compound or its tautomer, along with pharmaceutically acceptable salts, aimed at improving the safety and efficacy of treatments.

Career Highlights

Throughout his career, Duffy has made significant contributions while working at reputable companies such as Melinta Therapeutics, Inc. and Bioversys AG. His role in these organizations has facilitated advancements in the field of microbiology and pharmaceutical innovation.

Collaborations

Erin has collaborated with esteemed colleagues, including Ashoke Bhattacharjee and Zoltan F. Kanyo. Their joint efforts have resulted in impactful advancements in the research and development of antimicrobial strategies, further solidifying Duffy's reputation as a leader in this essential field.

Conclusion

In conclusion, Erin M. Duffy stands out as a dedicated innovator whose work is crucial in the fight against microbial infections. With his extensive patent portfolio and collaborative spirit, he continues to pave the way for future advancements in antimicrobial solutions, underscoring the vital importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…